209 results
8-K
EX-99.1
LLY
Lilly(Eli) & Co
30 Apr 24
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
7:04am
life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure
PX14A6G
As You Sow
11 Apr 24
Letter to shareholders
12:59pm
, has also been shown to encourage more creative and innovative workplace environments.11
By contrast, if the lack of diversity at a company is a result
PX14A6G
Trinity Health Corp
28 Mar 24
Letter to shareholders
12:20pm
, which receives innovative and improved medicines, as well as timely access to generic drugs.6
We believe that balance is now out of whack. Given … , reliance on patent thickets may actually diminish branded drug manufacturers’ incentives to continue developing innovative medicines
424B2
6pixdbk
8 Feb 24
Prospectus for primary offering
4:51pm
424B2
f5qzd61rmf
7 Feb 24
Prospectus for primary offering
8:12am
8-K
EX-99.1
guuz ej5dikx25
6 Feb 24
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
7:04am
SC TO-T/A
EX-99
lurnynrusf07bumtby
18 Dec 23
Third party tender offer statement (amended)
6:59am
SC TO-T/A
EX-99
0ycikjavlowpl00b w0n
4 Dec 23
Third party tender offer statement (amended)
7:04am
SC TO-T/A
EX-99
yxpcxc8r 8npjj2sk
17 Nov 23
Third party tender offer statement (amended)
6:53am
SC TO-T/A
EX-99
oqw1fl9e32jec zbct
15 Nov 23
Third party tender offer statement (amended)
6:51am
SC TO-T/A
EX-99
afps4 uf8p4p0ico8
8 Nov 23
Third party tender offer statement (amended)
5:06pm
8-K
EX-99.1
ktorxc
2 Nov 23
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity
7:02am
CORRESP
mbms1zj0c bevh8hz
26 Oct 23
Correspondence with SEC
12:00am
SC TO-C
EX-99.1
pj2dyibr
3 Oct 23
Information about tender offer
4:30pm
CORRESP
qtq32o zyeioqxxfyo
20 Sep 23
Correspondence with SEC
12:00am